These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38216120)

  • 21. Telomerase inhibitor MST-312 induces apoptosis of multiple myeloma cells and down-regulation of anti-apoptotic, proliferative and inflammatory genes.
    Ameri Z; Ghiasi S; Farsinejad A; Hassanshahi G; Ehsan M; Fatemi A
    Life Sci; 2019 Jul; 228():66-71. PubMed ID: 31029779
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeted inhibition of telomerase activity combined with chemotherapy demonstrates synergy in eliminating ovarian cancer spheroid-forming cells.
    Meng E; Taylor B; Ray A; Shevde LA; Rocconi RP
    Gynecol Oncol; 2012 Mar; 124(3):598-605. PubMed ID: 22115853
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined treatment with emodin and a telomerase inhibitor induces significant telomere damage/dysfunction and cell death.
    Liu R; Liu J; Wang S; Wang Y; Zhang T; Liu Y; Geng X; Wang F
    Cell Death Dis; 2019 Jul; 10(7):527. PubMed ID: 31296842
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Telomerase inhibition and telomere targeting in hematopoietic cancer cell lines with small non-nucleosidic synthetic compounds (BIBR1532).
    El Daly H; Martens UM
    Methods Mol Biol; 2007; 405():47-60. PubMed ID: 18369817
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differences in telomerase activity and the effects of AZT in aneuploid and euploid cells in colon cancer.
    Fang X; Hu T; Yin H; Yang J; Tang W; Hu S; Xu X
    Int J Oncol; 2017 Aug; 51(2):525-532. PubMed ID: 28627647
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanism of human telomerase inhibition by BIBR1532, a synthetic, non-nucleosidic drug candidate.
    Pascolo E; Wenz C; Lingner J; Hauel N; Priepke H; Kauffmann I; Garin-Chesa P; Rettig WJ; Damm K; Schnapp A
    J Biol Chem; 2002 May; 277(18):15566-72. PubMed ID: 11854300
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decitabine, a DNA methyltransferases inhibitor, induces cell cycle arrest at G2/M phase through p53-independent pathway in human cancer cells.
    Shin DY; Sung Kang H; Kim GY; Kim WJ; Yoo YH; Choi YH
    Biomed Pharmacother; 2013 May; 67(4):305-11. PubMed ID: 23582784
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kras mutations increase telomerase activity and targeting telomerase is a promising therapeutic strategy for Kras-mutant NSCLC.
    Liu W; Yin Y; Wang J; Shi B; Zhang L; Qian D; Li C; Zhang H; Wang S; Zhu J; Gao L; Zhang Q; Jia B; Hao L; Wang C; Zhang B
    Oncotarget; 2017 Jan; 8(1):179-190. PubMed ID: 27329725
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Consequences of telomerase inhibition by BIBR1532 on proliferation and chemosensitivity of chondrosarcoma cell lines.
    Parsch D; Brassat U; Brümmendorf TH; Fellenberg J
    Cancer Invest; 2008 Jul; 26(6):590-6. PubMed ID: 18584350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the anticancer effect of telomerase inhibitor BIBR1532 in anaplastic thyroid cancer in terms of apoptosis, migration and cell cycle.
    Turkmen E; Sogutlu F; Erdogan M; Biray Avci C
    Med Oncol; 2023 Jun; 40(7):196. PubMed ID: 37284891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening of telomerase inhibitors.
    Kleideiter E; Piotrowska K; Klotz U
    Methods Mol Biol; 2007; 405():167-80. PubMed ID: 18369824
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of telomerase recruitment and cancer cell death.
    Nakashima M; Nandakumar J; Sullivan KD; Espinosa JM; Cech TR
    J Biol Chem; 2013 Nov; 288(46):33171-80. PubMed ID: 24097987
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Non-Toxic Concentration of Telomerase Inhibitor BIBR1532 Fails to Reduce
    Pandya VA; Crerar H; Mitchell JS; Patani R
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33806803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BIBR1532 Affects Endometrial Cell Proliferation, Migration, and Invasion in Endometriosis via Telomerase Inhibition and MAPK Signaling.
    Zhao X; Luo D; Liu T; Zhang H; Xie Y; Kong W
    Gynecol Obstet Invest; 2023; 88(4):226-239. PubMed ID: 37429261
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Arsenic trioxide and BIBR1532 synergistically inhibit breast cancer cell proliferation through attenuation of NF-κB signaling pathway.
    Nasrollahzadeh A; Bashash D; Kabuli M; Zandi Z; Kashani B; Zaghal A; Mousavi SA; Ghaffari SH
    Life Sci; 2020 Sep; 257():118060. PubMed ID: 32645343
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Telomerase Inhibitor MST-312 Interferes with Multiple Steps in the Herpes Simplex Virus Life Cycle.
    Haberichter J; Roberts S; Abbasi I; Dedthanou P; Pradhan P; Nguyen ML
    J Virol; 2015 Oct; 89(19):9804-16. PubMed ID: 26178994
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Telomerase inhibitors and 'T-oligo' as cancer therapeutics: contrasting molecular mechanisms of cytotoxicity.
    Rankin AM; Faller DV; Spanjaard RA
    Anticancer Drugs; 2008 Apr; 19(4):329-38. PubMed ID: 18454043
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell-based chemical fingerprinting identifies telomeres and lamin A as modifiers of DNA damage response in cancer cells.
    Fujiwara C; Muramatsu Y; Nishii M; Tokunaka K; Tahara H; Ueno M; Yamori T; Sugimoto Y; Seimiya H
    Sci Rep; 2018 Oct; 8(1):14827. PubMed ID: 30287851
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design, synthesis and SARs of novel telomerase inhibitors based on BIBR1532.
    Liu C; Zhou H; Sheng XB; Liu XH; Chen FH
    Bioorg Chem; 2020 Sep; 102():104077. PubMed ID: 32682156
    [TBL] [Abstract][Full Text] [Related]  

  • 40. USP8 inhibitor-induced DNA damage activates cell cycle arrest, apoptosis, and autophagy in esophageal squamous cell carcinoma.
    Sha B; Sun Y; Zhao S; Li M; Huang W; Li Z; Shi J; Han X; Li P; Hu T; Chen P
    Cell Biol Toxicol; 2023 Oct; 39(5):2011-2032. PubMed ID: 35022897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.